CCL20-CCR6 Signaling as a Prognostic Biomarker and Therapeutic Target in Temozolomide-Resistant Glioblastoma
Ryan J. Green, Karthick Mayilsamy, Erin Anglin, Kristina Tosi, Sashank Bikkasani, Eleni Markoutsa, Parthvi Bharatkumar Patel, Tiara Wolf, Jennifer Guergues, Stanley M. Stevens, Ganesh V. Halade, Shyam Mohapatra, Subhra Mohapatra
This study identifies CCL20-CCR6 signaling as a prognostic biomarker and therapeutic target in temozolomide-resistant glioblastoma, showing that its inhibition enhances treatment response and induces tumor cell death.
bioRxiv · Aug 27, 2026 · PreprintCancer Biology